Tirzepatide is a once-weekly medication that activates two gut hormone receptors instead of one. Those receptors, GIP and GLP-1, help regulate appetite, insulin, and digestion. Here is a plain-English guide to how the dual approach works, what the FDA label says about approved uses, and how dosing typically steps up under a clinician’s guidance.
What a Dual GIP and GLP-1 Agonist Does
GIP, short for glucose-dependent insulinotropic polypeptide, and GLP-1 are hormones your gut releases after you eat. Tirzepatide is a dual agonist, meaning it binds to and activates both receptors. According to the FDA label for Zepbound, this reduces appetite and calorie intake, stimulates glucose-dependent insulin secretion, reduces glucagon secretion, and delays gastric emptying. The label also states that weight lost with tirzepatide includes more fat loss than lean mass loss. Cleveland Clinic describes tirzepatide as a dual GLP-1 and GIP agonist given once a week. Targeting two pathways is what sets it apart from medications that activate GLP-1 alone.
Tirzepatide Approved Uses and Dosing
The Zepbound label lists chronic weight reduction and long-term weight maintenance in adults with obesity, or with overweight plus a weight-related condition. It also lists moderate to severe obstructive sleep apnea in adults with obesity. Both uses pair with a reduced-calorie diet and more physical activity. Dosing starts low. Lilly lists a 2.5 mg weekly starting dose for 4 weeks, then 5 mg, with further 2.5 mg steps after at least 4 weeks on each dose. Maintenance doses for weight reduction are 5, 10, or 15 mg weekly. Your clinician sets the plan that fits you. A quick summary:
- Starting dose: 2.5 mg once weekly for 4 weeks
- Steps: 2.5 mg increases, at least 4 weeks apart
- Maintenance for weight reduction: 5, 10, or 15 mg weekly
Using Tirzepatide Alongside Healthy Habits and Follow-Up
Tirzepatide works best as part of a broader plan. The label calls for a reduced-calorie diet and increased physical activity, and it advises against combining tirzepatide with any other GLP-1 medication. It is given once a week, at any time of day, with or without meals, in the abdomen, thigh, or upper arm. The gradual dose steps give your body time to adjust. Regular follow-ups let your clinician review how you feel, check in on your habits, and decide whether to stay at your current dose or move up. Many people find that a steady weekly routine and honest check-ins make the whole process easier.
Frequently Asked Questions
What Does Dual GIP and GLP-1 Agonist Mean?
It means tirzepatide binds to and activates two gut hormone receptors, GIP and GLP-1. The FDA label says this reduces appetite and calorie intake and supports insulin release after meals.
How Often Is Tirzepatide Given?
Once a week, as an injection under the skin. The label says it can be given at any time of day, with or without meals, in the abdomen, thigh, or upper arm.
What Is Tirzepatide Approved For?
The label lists chronic weight reduction and maintenance in adults with obesity or overweight plus a weight-related condition, and moderate to severe obstructive sleep apnea in adults with obesity.
Can I Take Tirzepatide With Another GLP-1 Medication?
The label advises against using tirzepatide with other tirzepatide products or any other GLP-1 receptor agonist. Your clinician reviews all your medications before recommending a plan.
Good to Know
Common side effects are nausea, diarrhea, vomiting, constipation, and abdominal pain. Tell your clinician if you are pregnant, planning pregnancy, or have pancreatitis, kidney, or eye conditions. Avoid products sold online as research use only.
Explore Tirzepatide Options With a Licensed Clinician
If you are curious whether tirzepatide could fit your goals, a licensed clinician can help. Complete an online assessment, have an independent licensed clinician review your health history, and, when a prescription is appropriate, receive your medication from a licensed pharmacy that delivers to your door.
This article is for education only and is not medical advice.
